This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, N. P. Articles by Gown, A. M. Search for Related Content PubMed PubMed Citation Articles by Wang, N. P. Articles by Gown, A. M.

American Journal of Pathology, Vol 147, 1799-1810, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood

NP Wang, J Marx, MA McNutt, JC Rutledge and AM Gown
Department of Pathology, University of Washington, Seattle 98195, USA.

The distinction of rhabdomyosarcoma (RMS) from other small blue round cell tumors of childhood, such as Ewing's sarcoma/peripheral primitive neuroectodermal tumor (pPNET) and neuroblastoma, continues to present a diagnostic challenge to pathologists. The recent recognition of the master role of myogenic regulatory proteins in skeletal muscle commitment and differentiation, and the availability of monoclonal antibodies to two of them (myogenin and MyoD1), has prompted us to test their diagnostic utility in routinely processed, formalin-fixed, and deparaffinized tissue. Preliminary studies had demonstrated that, with the use of heat-induced epitope retrieval techniques, expression of myogenin and MyoD1 could be documented specifically in nuclei of fetal skeletal muscle by the respective antibodies. We performed a retrospective immunohistochemical analysis on 72 cases of small blue round cell tumors, including 33 RMSs, 1 metastatic myogenous Wilms' tumor, 26 Ewing's sarcomas/pPNETs, and 12 neuroblastomas. Nuclear expression of myogenin and MyoD1 were both found in 30/33 non- overlapping cases of RMS, with no significant differences in the sensitivity with respect to histological subtypes, and in 1/1 case of myogenous Wilms' tumor. None of the neuroblastomas or Ewing's sarcomas/pPNETs demonstrated positive nuclear staining with either antibody. However, most of the neuroblastomas, and occasional Ewing's sarcomas/pPNETs, showed variable fibrillary, cytoplasmic immunoreactivity with antibody to MyoD1. We conclude that, with the use of microwave-based epitope retrieval, antibodies to myogenin and MyoD1 are both useful markers for the identification of RMS among other small blue round cell tumors of childhood, but antibodies to myogenin have technical advantages over those to MyoD1, as the latter may cross-react with an unknown cytoplasmic antigen in non-muscle cells and tumors.

This article has been cited by other articles:

				S. Eliazer, J. Spencer, D. Ye, E. Olson, and R. L. Ilaria Jr. Alteration of Mesodermal Cell Differentiation by EWS/FLI-1, the Oncogene Implicated in Ewing's Sarcoma Mol. Cell. Biol., January 15, 2003; 23(2): 482 - 492. [Abstract] [Full Text] [PDF]

				R. Tibshirani, T. Hastie, B. Narasimhan, and G. Chu Diagnosis of multiple cancer types by shrunken centroids of gene expression PNAS, May 14, 2002; 99(10): 6567 - 6572. [Abstract] [Full Text] [PDF]

				K J Vincent, E Jones, M J P Arthur, D E Smart, J Trim, M C Wright, and D A Mann Regulation of E-box DNA binding during in vivo and in vitro activation of rat and human hepatic stellate cells Gut, November 1, 2001; 49(5): 713 - 719. [Abstract] [Full Text] [PDF]

				S. Modak, K. Kramer, S. H. Gultekin, H. F. Guo, and N.-K. V. Cheung Monoclonal Antibody 8H9 Targets a Novel Cell Surface Antigen Expressed by a Wide Spectrum of Human Solid Tumors Cancer Res., May 1, 2001; 61(10): 4048 - 4054. [Abstract] [Full Text]

				W. L. Gerald A Practical Approach to the Differential Diagnosis of Small Round Cell Tumors of Infancy Using Recent Scientific and Technical Advances International Journal of Surgical Pathology, April 1, 2000; 8(2): 87 - 97. [Abstract] [PDF]

				P. Dias, B. Chen, B. Dilday, H. Palmer, H. Hosoi, S. Singh, C. Wu, X. Li, J. Thompson, D. Parham, et al. Strong Immunostaining for Myogenin in Rhabdomyosarcoma Is Significantly Associated with Tumors of the Alveolar Subclass Am. J. Pathol., February 1, 2000; 156(2): 399 - 408. [Abstract] [Full Text] [PDF]

				S. Gattenloehner, B. Dockhorn-Dworniczak, I. Leuschner, A. Vincent, H.-K. Müller-Hermelink, and A. Marx A Comparison of MyoD1 and Fetal Acetylcholine Receptor Expression in Childhood Tumors and Normal Tissues: Implications for the Molecular Diagnosis of Minimal Disease in Rhabdomyosarcomas J. Mol. Diagn., November 1, 1999; 1(1): 23 - 31. [Abstract] [Full Text]